LY4050784 drug page Clinical trials

Trials with LY4050784

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
6Countries
340Planned patients

Showing 1–1 of 1

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Ongoing, not recruiting Phase 1 340 patients NCT06561685

The main purpose of this study is to find out whether the study drug, LY4050784, is safe, tolerable and effective in participants alone or in combination with other anticancer agents. In addition, with locally advanced or metastatic solid …

United States, France, Germany, Japan and 2 more Sept 2024 – Oct 2027 Interventional